14605-22-2 Tauroursodeoxycholic acid dihydrate AKSci M937
 
 
Loading Please Wait...
  M937    
Tauroursodeoxycholic acid dihydrate
, 98%
 
3alpha,7beta-Dihydroxy-5beta-cholan-24-oic acid N-(2-sulfoethyl)amide
TUDCA




IDENTITY
CAS Number:14605-22-2
MDL Number:MFCD09750398
MF:C26H45NO6S.2H2O
MW:499.71 (anhydrous)
SPECIFICATIONS & PROPERTIES
Min. Purity Spec:98%
Physical Form:White to off-white powder or crystals
Melting Point:139-153°C
Optical Rotation:+42-+48° (c=1, EtOH)
Long-Term Storage:Store long-term in a cool, dry place
HAZARDOUS MATERIALS INFORMATION
Not hazardous material

REVIEW

 Tauroursodeoxycholic acid (TUDCA) is an ambiphilic bile acid and is the conjugate form of ursodeoxycholic acid and taurine. Ongoing research finds TUDCA has apoptotic effects, helping with cardiac function, Huntington's disease, Parkinson's Disease, and stroke. Recently, TUDCA has been found to have protective effects in the eye, especially for retinal degenerative disorders. Bax, a molecule that is translocated to the mitochondria to release cytochrome C, initiates the cellular pathway of apoptosis. TUDCA prevents Bax from being transported to the mitochondria. This protects the mitochondria from perturbation and the activation of caspases; therefore TUDCA acts as a chemical chaperone. Recent studies continue to show ocular protective effects via protecting retinal rods against apoptosis, choroidal neovascularization and synaptic connectivity.

REFERENCES
[1]Bonaldi, Antonio; Molinari, Egidio Preparation of taurine-conjugated bile acids Eur. Pat. Appl. (1994), EP 582891 A2 19940216.
[2] Huang, Ling; Zhang, Heping; Qin, Heping; Shen, Huibing; Huang, Wenjun; Liu, Yisong Method for preparation of tauroursodeoxycholic acid hydrate Faming Zhuanli Shenqing (2012), CN 102558268 A 20120711.
[3] Boatright, Jeffrey H.; Nickerson, John M.; Moring, Anisha G.; Pardue, Machelle T. Bile acids in treatment of ocular diseases. Journal of Ocular Biology, Diseases, and Informatics 2009, 2 (3): 149-159.
[4] Boatright, Jeffrey H, Nickerson, John M, Moring, Anisha G, Pardue, Machelle T. Bile acids in treatment of ocular diseas. J Ocul Biol Dis Infor 2009, 2 (3): 149-159.

GHS

Pictograms

Signal Word
Warning

Hazard Statements
H315; H319; H335

Precautionary Statements
P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501


RELATED PRODUCTS
M937Tauroursodeoxycholic acid dihydrate
4482ABSodium tauroursodeoxycholate

Current as of June 20, 2021


Download SDS

For research use only. Not for diagnostic or therapeutic use. Not for human use. AK Scientific, Inc. does not sell to individuals. If you are a first-time customer, please email for review at least two official business documents issued by your local jurisdiction, state/province, or country.


CATEGORIES

 APIs and Bioactives > Bile Acids


PubChem
  @PubMed